Anna Guzman

1.7k total citations
20 papers, 988 citations indexed

About

Anna Guzman is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Anna Guzman has authored 20 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Hematology and 4 papers in Genetics. Recurrent topics in Anna Guzman's work include Acute Myeloid Leukemia Research (13 papers), Epigenetics and DNA Methylation (11 papers) and RNA modifications and cancer (4 papers). Anna Guzman is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Epigenetics and DNA Methylation (11 papers) and RNA modifications and cancer (4 papers). Anna Guzman collaborates with scholars based in United States, China and Italy. Anna Guzman's co-authors include Margaret A. Goodell, Mira Jeong, Wei Li, Yun Huang, Yung‐Hsin Huang, Yong Lei, Hyun Jung Park, Jianzhong Su, Xiaotian Zhang and Myunggon Ko and has published in prestigious journals such as Nature Communications, Nature Genetics and Blood.

In The Last Decade

Anna Guzman

17 papers receiving 974 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Guzman United States 12 668 442 253 117 88 20 988
Jacques Zaneveld United States 10 450 0.7× 370 0.8× 147 0.6× 65 0.6× 49 0.6× 13 749
Philippe Brunet de la Grange France 14 294 0.4× 449 1.0× 270 1.1× 136 1.2× 135 1.5× 38 838
Alexey Bersenev United States 14 450 0.7× 228 0.5× 238 0.9× 90 0.8× 230 2.6× 24 838
Ngaire Elwood Australia 15 465 0.7× 226 0.5× 124 0.5× 79 0.7× 74 0.8× 44 846
Shoichiro Takeishi Japan 12 534 0.8× 275 0.6× 124 0.5× 118 1.0× 298 3.4× 16 940
Remco M. Hoogenboezem Netherlands 20 530 0.8× 514 1.2× 271 1.1× 141 1.2× 225 2.6× 51 1.2k
Vionnie W.C. Yu United States 13 571 0.9× 419 0.9× 120 0.5× 160 1.4× 161 1.8× 22 1.0k
Kumi Nakazaki Japan 10 543 0.8× 209 0.5× 143 0.6× 151 1.3× 154 1.8× 34 996
Amir Schajnovitz United States 10 420 0.6× 461 1.0× 209 0.8× 100 0.9× 188 2.1× 20 1.0k
Jason Levine United States 7 732 1.1× 582 1.3× 125 0.5× 184 1.6× 353 4.0× 20 1.2k

Countries citing papers authored by Anna Guzman

Since Specialization
Citations

This map shows the geographic impact of Anna Guzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Guzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Guzman more than expected).

Fields of papers citing papers by Anna Guzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Guzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Guzman. The network helps show where Anna Guzman may publish in the future.

Co-authorship network of co-authors of Anna Guzman

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Guzman. A scholar is included among the top collaborators of Anna Guzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Guzman. Anna Guzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Tingting, Jia Li, Tianlu Wang, et al.. (2023). TET2 modulates spatial relocalization of heterochromatin in aged hematopoietic stem and progenitor cells. Nature Aging. 3(11). 1387–1400. 21 indexed citations
2.
Gu, Tianpeng, Dapeng Hao, Junsung Woo, et al.. (2022). The disordered N-terminal domain of DNMT3A recognizes H2AK119ub and is required for postnatal development. Nature Genetics. 54(5). 625–636. 37 indexed citations
3.
Tovy, Ayala, Jaime M. Reyes, Linda Zhang, et al.. (2022). Constitutive loss of DNMT3A causes morbid obesity through misregulation of adipogenesis. eLife. 11. 15 indexed citations
5.
Gupta, Rohit, Jaime M. Reyes, Michael C. Gundry, et al.. (2021). Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities. Blood Advances. 5(19). 3876–3890. 6 indexed citations
6.
Sportoletti, Paolo, Daniele Sorcini, Anna Guzman, et al.. (2020). Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice. Leukemia. 35(7). 1949–1963. 9 indexed citations
7.
Guo, Lei, Jia Li, Hongxiang Zeng, et al.. (2020). A combination strategy targeting enhancer plasticity exerts synergistic lethality against BETi-resistant leukemia cells. Nature Communications. 11(1). 740–740. 35 indexed citations
8.
Zhang, Xiaotian, Xinyu Wang, Xue Qing David Wang, et al.. (2020). Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis. Blood. 135(11). 845–856. 28 indexed citations
9.
Zeng, Hongxiang, Hailan He, Lei Guo, et al.. (2019). Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies. Cancer Letters. 467. 1–8. 29 indexed citations
10.
Li, Jia, Hongxiang Zeng, Anna Guzman, et al.. (2019). A Combination Strategy Targeting Enhancer Plasticity Exerts Synergistic Lethality Against Beti-Resistant Leukemia Cells. Blood. 134(Supplement_1). 5053–5053. 3 indexed citations
11.
Brunetti, Lorenzo, Michael C. Gundry, Daniele Sorcini, et al.. (2018). Mutant NPM1 Maintains the Leukemic State through HOX Expression. Cancer Cell. 34(3). 499–512.e9. 195 indexed citations
12.
Gu, Tianpeng, Xueqiu Lin, Sean M. Cullen, et al.. (2018). DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells. Genome biology. 19(1). 88–88. 105 indexed citations
13.
Tovy, Ayala, Hyun Jung Park, Jaime M. Reyes, et al.. (2018). Mosaic DNMT3A Germline Mutation As a Model for Mutant DNMT3A Competitive Advantage in the Blood Lineage. Blood. 132(Supplement 1). 173–173.
14.
Huang, Yung‐Hsin, Ayala Tovy, Jianzhong Su, et al.. (2018). Nearly a Third of Clonal Hematopoiesis-Associated DNMT3A Mutations Reduce Protein Stability and May be Associated with Poorer Prognosis. Blood. 132(Supplement 1). 1315–1315. 1 indexed citations
15.
Jeong, Mira, Hyun Jung Park, Hamza Celik, et al.. (2018). Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo. Cell Reports. 23(1). 1–10. 151 indexed citations
16.
17.
Wang, Jarey H., Anna Guzman, Sean M. Cullen, et al.. (2017). Loss of De Novo DNA Methyltransferase DNMT3A Impacts Alternative Splicing in Hematopoietic Stem Cells. Blood. 130. 1–1. 11 indexed citations
18.
Jeong, Mira, Anna Guzman, & Margaret A. Goodell. (2017). Genome-Wide Analysis of DNA Methylation in Hematopoietic Cells: DNA Methylation Analysis by WGBS. Methods in molecular biology. 1633. 137–149. 5 indexed citations
19.
Zhang, Xiaotian, Jianzhong Su, Mira Jeong, et al.. (2016). DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells. Nature Genetics. 48(9). 1014–1023. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026